Nuvalent (NUVL) News Today $79.49 -2.90 (-3.52%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$79.60 +0.11 (+0.14%) As of 02/21/2025 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period James Richard Porter Sells 27,000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CEO James Richard Porter sold 27,000 shares of the company's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $78.46, for a total transaction of $2,118,420.00. Following the completion of the transaction, the chief executive officer now owns 249,062 shares in the company, valued at $19,541,404.52. This trade represents a 9.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.February 21 at 5:28 PM | marketbeat.comNuvalent (NUVL) Projected to Post Quarterly Earnings on TuesdayNuvalent (NASDAQ:NUVL) will be releasing earnings on Tuesday, February 25, Financial Modeling Prep reports.February 18, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Average Target Price from BrokeragesFebruary 15, 2025 | americanbankingnews.comWhy Insiders Are Selling Nuvalent, Inc. (NUVL) RecentlyFebruary 11, 2025 | msn.comNuvalent, Inc. (NASDAQ:NUVL) Holdings Lifted by abrdn plcabrdn plc raised its position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 19.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,701 shares of the company's stock after purchasing an additional 9,241 shares during thFebruary 10, 2025 | marketbeat.comQ1 Earnings Forecast for Nuvalent Issued By Leerink PartnrsNuvalent, Inc. (NASDAQ:NUVL - Free Report) - Stock analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Nuvalent in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will post earnings of ($1.14) per share for theFebruary 10, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Nuvalent, Inc. (NASDAQ:NUVL - Get Free Report) have been assigned an average rating of "Moderate Buy" from the fourteen analysts that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has given a hold ratingFebruary 10, 2025 | marketbeat.comQ2 Earnings Forecast for Nuvalent Issued By Leerink PartnrsNuvalent, Inc. (NASDAQ:NUVL - Free Report) - Equities research analysts at Leerink Partnrs issued their Q2 2025 EPS estimates for Nuvalent in a report released on Wednesday, February 5th. Leerink Partnrs analyst A. Berens expects that the company will post earnings of ($1.17) per share for the quFebruary 7, 2025 | marketbeat.comNuvalent (NASDAQ:NUVL) Is In A Good Position To Deliver On Growth PlansFebruary 6, 2025 | uk.finance.yahoo.comNuvalent, Inc. (NASDAQ:NUVL) Director Sells $165,580.00 in StockJanuary 30, 2025 | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Holdings Boosted by SG Americas Securities LLCSG Americas Securities LLC boosted its holdings in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 46.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,793 shares of the company's stock after acquiring an additiJanuary 30, 2025 | marketbeat.comMatthew Shair Sells 2,000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) Director Matthew Shair sold 2,000 shares of the business's stock in a transaction dated Monday, January 27th. The shares were sold at an average price of $82.79, for a total value of $165,580.00. Following the completion of the transaction, the director now directly owns 218,522 shares in the company, valued at $18,091,436.38. This represents a 0.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.January 29, 2025 | marketbeat.comNuvalent director Matthew Shair sells shares worth $165,575January 29, 2025 | msn.comNuvalent: A First LookJanuary 22, 2025 | seekingalpha.comIs Nuvalent, Inc. (NUVL) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?January 20, 2025 | msn.comNuvalent, Inc. (NASDAQ:NUVL) CEO Sells $2,051,730.00 in StockJanuary 18, 2025 | insidertrades.comNuvalent stock reiterates buy rating on FDA approval potentialJanuary 17, 2025 | msn.comNuvalent’s Clinical Advancements and Strategic Growth Drive Buy Rating with $110 Price TargetJanuary 17, 2025 | markets.businessinsider.comNuvalent, Inc. (NASDAQ:NUVL) CEO James Richard Porter Sells 27,000 SharesNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CEO James Richard Porter sold 27,000 shares of the firm's stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $75.99, for a total value of $2,051,730.00. Following the completion of the sale, the chief executive officer now directly owns 249,062 shares of the company's stock, valued at approximately $18,926,221.38. This trade represents a 9.78 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.January 17, 2025 | marketbeat.comNuvalent (NASDAQ:NUVL) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $110.00 target price on shares of Nuvalent in a research note on Friday.January 17, 2025 | marketbeat.comNuvalent's SWOT analysis: biotech stock shows promise amid clinical progressJanuary 16, 2025 | msn.comNuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the fourteen brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, elevenJanuary 16, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Nuvalent (NUVL)January 15, 2025 | markets.businessinsider.comBarclays Reaffirms Their Buy Rating on Nuvalent (NUVL)January 14, 2025 | markets.businessinsider.comNuvalent’s Strategic Progress and Clinical Advancements Justify Buy RatingJanuary 14, 2025 | markets.businessinsider.comNuvalent (NASDAQ:NUVL) Given "Outperform" Rating at WedbushWedbush restated an "outperform" rating and set a $115.00 target price on shares of Nuvalent in a report on Monday.January 13, 2025 | marketbeat.comNuvalent Details Strategy to Seek First Potential Approval in 2026 and Outlines Key Anticipated 2025 MilestonesJanuary 13, 2025 | prnewswire.comNuvalent: A Logical Acquisition TargetJanuary 10, 2025 | seekingalpha.comNuvalent, Inc. (NASDAQ:NUVL) Insider Sells $197,845.44 in StockJanuary 9, 2025 | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Insider Sells $197,845.44 in StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) insider Henry E. Pelish sold 2,483 shares of the firm's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $79.68, for a total transaction of $197,845.44. Following the completion of the transaction, the insider now owns 59,981 shares of the company's stock, valued at approximately $4,779,286.08. The trade was a 3.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.January 8, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) CFO Sells $319,994.88 in StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CFO Alexandra Balcom sold 4,016 shares of the firm's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $79.68, for a total transaction of $319,994.88. Following the completion of the transaction, the chief financial officer now directly owns 61,734 shares in the company, valued at $4,918,965.12. This represents a 6.11 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.January 8, 2025 | marketbeat.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) CEO Sells 17,301 Shares of StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CEO James Richard Porter sold 17,301 shares of Nuvalent stock in a transaction on Monday, January 6th. The stock was sold at an average price of $79.68, for a total transaction of $1,378,543.68. Following the sale, the chief executive officer now directly owns 249,062 shares of the company's stock, valued at $19,845,260.16. This represents a 6.50 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.January 8, 2025 | marketbeat.comHC Wainwright Comments on Nuvalent FY2024 EarningsNuvalent, Inc. (NASDAQ:NUVL - Free Report) - Investment analysts at HC Wainwright issued their FY2024 earnings per share estimates for shares of Nuvalent in a research report issued on Monday, December 30th. HC Wainwright analyst S. Ramakanth expects that the company will post earnings per shareJanuary 1, 2025 | marketbeat.comNuvalent initiated with a Buy at H.C. WainwrightDecember 31, 2024 | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of Nuvalent (NUVL) with Buy RecommendationDecember 30, 2024 | msn.comNuvalent (NASDAQ:NUVL) Coverage Initiated at HC WainwrightHC Wainwright started coverage on shares of Nuvalent in a research report on Monday. They issued a "buy" rating and a $110.00 price target on the stock.December 30, 2024 | marketbeat.comInsider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 2,000 Shares of StockDecember 27, 2024 | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Director Sells $167,560.00 in StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) Director Matthew Shair sold 2,000 shares of the firm's stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $83.78, for a total transaction of $167,560.00. Following the completion of the transaction, the director now directly owns 220,522 shares in the company, valued at $18,475,333.16. This represents a 0.90 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.December 26, 2024 | marketbeat.comNuvalent (NASDAQ:NUVL) Stock Price Down 2.4% - Here's WhyNuvalent (NASDAQ:NUVL) Shares Down 2.4% - Here's WhyDecember 24, 2024 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Nuvalent, Inc. (NASDAQ:NUVL - Get Free Report) have received a consensus rating of "Moderate Buy" from the thirteen analysts that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendDecember 22, 2024 | marketbeat.comFranklin Resources Inc. Has $16.49 Million Stock Position in Nuvalent, Inc. (NASDAQ:NUVL)Franklin Resources Inc. lessened its holdings in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 18.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 159,628 shares of the company's stock after selling 35,063 sharesDecember 21, 2024 | marketbeat.comGeode Capital Management LLC Acquires 73,429 Shares of Nuvalent, Inc. (NASDAQ:NUVL)Geode Capital Management LLC boosted its stake in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 9.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 855,610 shares of the company's stock afteDecember 20, 2024 | marketbeat.comNuvalent to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 19, 2024 | prnewswire.comBarclays PLC Has $6.97 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL)Barclays PLC boosted its holdings in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 149.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 68,107 shares of the company's stock after buying an additional 40,754 shares dDecember 19, 2024 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) CEO Sells $2,338,470.00 in StockNuvalent, Inc. (NASDAQ:NUVL - Get Free Report) CEO James Richard Porter sold 27,000 shares of the company's stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $86.61, for a total value of $2,338,470.00. Following the completion of the sale, the chief executive officer now owns 188,113 shares of the company's stock, valued at approximately $16,292,466.93. The trade was a 12.55 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.December 18, 2024 | marketbeat.comLord Abbett & CO. LLC Purchases 70,157 Shares of Nuvalent, Inc. (NASDAQ:NUVL)Lord Abbett & CO. LLC grew its position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 29.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 308,362 shares of the company's stock after acquiring an addiDecember 16, 2024 | marketbeat.comVirtu Financial LLC Purchases Shares of 7,417 Nuvalent, Inc. (NASDAQ:NUVL)Virtu Financial LLC acquired a new position in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) during the third quarter, according to its most recent filing with the SEC. The firm acquired 7,417 shares of the company's stock, valued at approximately $759,000. Several other hedge funds have also recentlyDecember 15, 2024 | marketbeat.comState Street Corp Decreases Position in Nuvalent, Inc. (NASDAQ:NUVL)State Street Corp reduced its stake in Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 6.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,243,099 shares of the company's stock after selling 82,December 15, 2024 | marketbeat.com12,264 Shares in Nuvalent, Inc. (NASDAQ:NUVL) Bought by Y Intercept Hong Kong LtdY Intercept Hong Kong Ltd acquired a new position in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 12,264 shares of the company's stock, valued at approximately $1,255,000. Several other institutDecember 12, 2024 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Shares Purchased by Wellington Management Group LLPWellington Management Group LLP grew its holdings in shares of Nuvalent, Inc. (NASDAQ:NUVL - Free Report) by 65.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,011,837 shares of the company's stock after purchasing anDecember 10, 2024 | marketbeat.com Get Nuvalent News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter. Email Address NUVL Media Mentions By Week NUVL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVL News Sentiment▼-0.030.60▲Average Medical News Sentiment NUVL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVL Articles This Week▼35▲NUVL Articles Average Week Get Nuvalent News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News Today SMMT News Today GMAB News Today ITCI News Today VTRS News Today MRNA News Today RDY News Today PCVX News Today SRPT News Today QGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NUVL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvalent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
